Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-07-29

Clinical Trial Update: Tirzepatide for the Treatment of Concurrent Type 1 Diabetes and Overweight or Obesity [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for tirzepatide in adults with Type 1 diabetes mellitus and overweight/obesity. The study status is NOT_YET_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tirzepatide (tirzepatide)

Snippet

Sponsor: Royal North Shore Hospital | Conditions: Type 1 Diabetes Mellitus, Overweight and Obesity | Phase 2 | Status: NOT_YET_RECRUITING